影像组学可在化疗后腹膜后淋巴结清扫术前检测转移性睾丸生殖细胞肿瘤患者的良恶性组织病理学
本研究纳入80例转移性非精原细胞性睾丸生殖细胞肿瘤患者,基于化疗后腹膜后淋巴结清扫术前CT提取淋巴结影像组学特征,训练梯度提升树分类器预测淋巴结病理良恶性。验证集分类准确率0.81,敏感度88%、特异度72%、阴性预测值88%;仅用淋巴结体积的模型准确率0.68、敏感度64%、特异度68%。作者认为CT影像组学有助减少过度治疗,建议结合临床生物标志物并在更大前瞻性试验中进一步验证。
要点
- 验证集中影像组学分类器区分良恶性淋巴结的准确率为0.81,敏感度88%、特异度72%。
- 仅用淋巴结体积的模型准确率0.68、敏感度64%、特异度68%,低于影像组学模型。
- 36枚良性淋巴结中8枚误判为恶性,25枚恶性淋巴结中4枚误判为良性。
核心结论
- CT影像组学是改善预测非精原细胞性睾丸生殖细胞肿瘤腹膜后淋巴结转移中恶性组织病理存在的新工具,旨在减少该组年轻患者的过度治疗。
- 作者建议将该方法与已有临床生物标志物结合,并在更大规模的前瞻性临床试验中进一步验证。
研究设计与样本
- 回顾性研究,纳入80例有腹膜后淋巴结转移且行增强CT的转移性非精原细胞性睾丸生殖细胞肿瘤患者。
- 手术切除淋巴结按病理分为良性(坏死/纤维化)或恶性(存活肿瘤/畸胎瘤),共对204枚对应淋巴结进行分割。
- 经标准化图像处理后每枚淋巴结提取97个影像组学特征,数据集分为训练集、测试集和验证集。
- 经基于可重复性、变量重要性和相关分析逐步降维后,用训练集和测试集训练并调优梯度提升树,在独立验证集上验证。
诊断标准与关键数值
- 验证集分类准确率0.81,敏感度88%、特异度72%、阴性预测值88%。
- 验证集中36枚良性淋巴结有8枚误分类为恶性,25枚恶性淋巴结有4枚误分类为良性。
- 仅含淋巴结体积的模型分类准确率0.68,敏感度64%、特异度68%。
临床应用与阅片要点
- 作者认为CT影像组学可用于预测化疗后腹膜后淋巴结转移中存活肿瘤或畸胎瘤的存在,目标是减少年轻患者的过度治疗。
- 作者建议将该方法与已有临床生物标志物结合,并在更大规模的前瞻性临床试验中进一步验证。
局限性
- 原文为回顾性研究。
- 作者指出该方法应在更大规模的前瞻性临床试验中进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate whether a computed tomography (CT) radiomics-based machine learning classifier can predict histopathology of lymph nodes (LNs) after post-chemotherapy LN dissection (pcRPLND) in patients with metastatic non-seminomatous testicular germ cell tumors (NSTGCTs).
METHODS: Eighty patients with retroperitoneal LN metastases and contrast-enhanced CT were included into this retrospective study. Resected LNs were histopathologically classified into "benign" (necrosis/fibrosis) or "malignant" (viable tumor/teratoma). On CT imaging, 204 corresponding LNs were segmented and 97 radiomic features per LN were extracted after standardized image processing. The dataset was split into training, test, and validation sets. After stepwise feature reduction based on reproducibility, variable importance, and correlation analyses, a gradient-boosted tree was trained and tuned on the selected most important features using the training and test datasets. Model validation was performed on the independent validation dataset.
RESULTS: The trained machine learning classifier achieved a classification accuracy of 0.81 in the validation dataset with a misclassification of 8 of 36 benign LNs as malignant and 4 of 25 malignant LNs as benign (sensitivity 88%, specificity 72%, negative predictive value 88%). In contrast, a model containing only the LN volume resulted in a classification accuracy of 0.68 with 64% sensitivity and 68% specificity.
CONCLUSIONS: CT radiomics represents an exciting new tool for improved prediction of the presence of malignant histopathology in retroperitoneal LN metastases from NSTGCTs, aiming at reducing overtreatment in this group of young patients. Thus, the presented approach should be combined with established clinical biomarkers and further validated in larger, prospective clinical trials.
KEY POINTS: • Patients with metastatic non-seminomatous testicular germ cell tumors undergoing post-chemotherapy retroperitoneal lymph node dissection of residual lesions show overtreatment in up to 50%. • We assessed whether a CT radiomics-based machine learning classifier can predict histopathology of lymph nodes after post-chemotherapy lymph node dissection. • The trained machine learning classifier achieved a classification accuracy of 0.81 in the validation dataset with a sensitivity of 88% and a specificity of 78%, thus allowing for prediction of the presence of viable tumor or teratoma in retroperitoneal lymph node metastases.
引用
- Baessler B, Nestler T, Pinto Dos Santos D, et al. Radiomics allows for detection of benign and malignant histopathology in patients with metastatic testicular germ cell tumors prior to post-chemotherapy retroperitoneal lymph node dissection. Eur Radiol. 2019. PMID: 31828413. doi:10.1007/s00330-019-06495-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。